Pulmonary Hypertension in the Critical Care Setting: Classification, Pathophysiology, Diagnosis, and Management

Critical Care Clinics

Volumn 23, Issue 4, 2007, Pages 801-834

  Rubenfire, Melvyn ^a   Bayram, Melike ^a   Hector Word, Zachary ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; ACUTE HEART FAILURE; CHRONIC DISEASE; DEATH; DISABILITY; DISEASE CLASSIFICATION; ENTEROPATHY; HEART FAILURE; HEART OUTPUT; HUMAN; HYPOTENSION; HYPOXEMIA; INTENSIVE CARE; KIDNEY DISEASE; LIVER CONGESTION; LUNG EMBOLISM; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; TREATMENT PLANNING;

ACUTE DISEASE; ALGORITHMS; CARDIOVASCULAR AGENTS; CHRONIC DISEASE; CRITICAL CARE; HUMANS; HYPERTENSION, PULMONARY; THROMBOEMBOLISM;

EID: 35349025340     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2007.07.006     Document Type: Review

References (53)

1. Simonneau G., Galie N., Rubin L.J., et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 43 12 Suppl S (2004) 5S-12S
2. Barst R.J., McGoon M., Torbicki A., et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 43 12 Suppl S (2004) 40S-47S
3. Gaines S. Pulmonary hypertension. JAMA 284 (2000) 3160-3168
4. Humbert M., Morrell N.W., Archer S.L., et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 43 12 Suppl S (2004) 13S-24S
5. McGoon M., Gutterman D., Steen V., et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126 Suppl 1 (2004) 14S-34S
6. Bossone E., Butera G., Bodini B.D., et al. The interpretation of the electrocardiogram in patients with pulmonary hypertension: the need for clinical correlation. Ital Heart J 4 12 (2003) 850-854
7. Stein P.D., Goldhaber S.Z., Henry J.W., et al. Arterial blood gas analysis in the assessment of suspected pulmonary embolism. Chest 109 (1996) 78-81
8. Bossone E., Duong-Wagner T., Paciocco G., et al. Echocardiographic features of primary pulmonary hypertension. J Am Soc Echocardiogr 12 8 (1999) 655-662
9. McConnell M.V., Solomon S.D., Rayan M.E., et al. Regional right ventricular dysfunction detected by echocardiography in acute pulmonary embolism. Am J Cardiol 78 4 (1996) 469-473
10. Kruip M.J., Leclercq M.G., van der Heul C., et al. Diagnostic strategies for excluding pulmonary embolism in clinical outcome studies. A systematic review. Ann Intern Med 138 12 (2003) 941-951
11. van Strijen M.J., de Monye W., Schiereck J., et al. Single-detector helical computed tomography as the primary diagnostic test in suspected pulmonary embolism: a multicenter clinical management study of 510 patients. Ann Intern Med 138 4 (2003) 307-314
12. Stein P.D., Fowler S.E., Goodman L.R., et al. Multidetector computed tomography for acute pulmonary embolism. N Engl J Med 354 22 (2006) 2317-2327
13. Kelly A.M., Patel S., Carlos R.C., et al. Multidetector row CT pulmonary angiography and indirect venography for the diagnosis of venous thromboembolic disease in intensive care unit patients. Acad Radiol 13 4 (2006) 486-495
14. The PIOPED Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism: result of the prospective investigators of pulmonary embolism diagnosis (PIOPED). JAMA 263 (1990) 2753-2759
15. Henry J.W., Stein P.D., Gottschalk A., et al. Scintigraphic lung scans and clinical assessment in critically ill patients with suspected acute pulmonary embolism. Chest 109 2 (1996) 462-466
16. Konstantinides S., Geibel A., Olschewski M., et al. Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism. Circulation 106 10 (2002) 1263-1268
17. Kucher N., and Goldhaber S.Z. Cardiac biomarkers for risk stratification of patients with acute pulmonary embolism. Circulation 108 18 (2003) 2191-2194
18. Torbicki A., Kurzyna M., Kuca P., et al. Detectable serum cardiac troponin T as a marker of poor prognosis among patients with chronic precapillary pulmonary hypertension. Circulation 108 (2003) 844-848
19. Kucher N., Printzen G., and Goldhaber S.Z. Prognostic role of brain natriuretic peptide in acute pulmonary embolism. Circulation 107 20 (2003) 2545-2547
20. Nagaya N., Nishikimi T., Uematsu M., et al. Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. Circulation 102 8 (2000) 865-870
21. Chemla D., Castelain V., Herve P., et al. Hemodynamic evaluation of pulmonary hypertension. Eur Respir J 20 (2002) 1314-1331
22. McLaughlin V.V., Presberg K.W., Doyle R.L., et al. Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126 (2004) 78-92
23. Sitbon O., Humbert M., Jaïs X., et al. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation 111 (2005) 3105-3111
24. Quinlan D.J., McQuillan A., and Eikelboom J.W. Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a meta-analysis of randomized, controlled trials. Ann Intern Med 140 (2004) 175-183
25. Mismetti P., Quenet S., Levine M., et al. Enoxaparin in the treatment of deep vein thrombosis with or without pulmonary embolism: an individual patient data meta-analysis. Chest 128 4 (2005) 2203-2210
26. Ridker P.M., Goldhaber S.Z., Danielson E., et al. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med 348 15 (2003) 1425-1434
27. Kearon C., Ginsberg J.S., Kovacs M.J., et al. Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. N Engl J Med 349 7 (2003) 631-639
28. Kucher N., Rossi E., De Rosa M., et al. Prognostic role of echocardiography among patients with acute pulmonary embolism and a systolic arterial pressure of 90 mm Hg or higher. Arch Intern Med 165 (2005) 1777-1781
29. Quiroz R., Kucher N., Schoepf U.J., et al. Right ventricular enlargement on chest computed tomography: prognostic role in acute pulmonary embolism. Circulation 109 (2004) 2401-2404
30. Kasper W., Konstantinides S., Geibel A., et al. Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J Am Coll Cardiol 30 (1997) 1165-1171
31. Aklog L., Williams C.S., Byrne J.G., et al. Acute pulmonary embolectomy: a contemporary approach. Circulation 105 (2002) 1416-1419
32. Konstantinides S., Geibel A., Heusel G., et al. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 347 (2002) 1143-1150
33. Wan S., Quinlan D.J., Agnelli G., et al. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials. Circulation 110 (2004) 744-749
34. Decousus H., Leizorovicz A., Parent F., et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. N Engl J Med 338 (1998) 409-415
35. Moser K.M., and Bloor C.M. Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension. Chest 103 (1993) 685-692
36. Jamieson S.W., Kapelanski D.P., Sakakibara N., et al. Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg 76 (2003) 1457-1462
37. Bresser P., Fedullo P.F., Auger W.R., et al. Continuous intravenous epoprostenol for chronic thromboembolic pulmonary hypertension. Eur Respir J 23 (2004) 595-600
38. Olschewski H., Simonneau G., Galie N., et al. Aerosolized Iloprost Randomized Study Group. Inhaled iloprost for severe pulmonary hypertension. N Engl J Med 347 5 (2002) 322-329
39. Ghofrani H.A., Schermuly R.T., Rose F., et al. Sildenafil for long-term treatment of nonoperable chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 167 (2003) 1139-1141
40. Hughes R.J., Jais X., Bonderman D., et al. The efficacy of bosentan in inoperable chronic thromboembolic pulmonary hypertension: a 1-year follow-up study. Eur Respir J 28 (2006) 138-143
41. Lang I., Gomez-Sanchez M., Kneussl M., et al. Efficacy of long-term subcutaneous treprostinil sodium therapy in pulmonary hypertension. Chest 129 (2006) 1636-1643
42. Sandroni C., Maggiore S.M., Proietti R., et al. Cardiopulmonary resuscitation in patients with pulmonary arterial hypertension. Am J Respir Crit Care Med 167 (2003) 664-665
43. Fuster V., Steele P.M., Edwards W.D., et al. Primary pulmonary hypertension: natural history and importance of thrombosis. Circulation 70 (1984) 580-587
44. Badesch D.B., Abman S.H., Ahearn G.S., et al. Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126 (2004) 35-62
45. Rubin L.J., Badesch D.B., Barst R.J., et al. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 346 (2002) 896-903
46. Barst R.J., Langleben D., Badesch D., et al., STRIDE-2 Study Group. Treatment of pulmonary arterial hypertension with selective endothelin-A receptor antagonist sitaxsentan. J Am Coll Cardiol 47 (2006) 2049-2056
47. Galiè N., Ghofrani H.A., Torbicki A., et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 353 (2005) 2148-2157
48. Barst R.J., Rubin L.J., Long W.A., et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med 334 (1996) 296-302
49. McLaughlin V.V., Shillington A., and Rich S. Survival in primary pulmonary hypertension: the impact of epoprostenol therapy. Circulation 106 (2002) 1477-1482
50. McLaughlin V.V., Gaine S.P., Barst R.J., et al. Efficacy and safety of trepostinil, a prostacyclin analogue for primary pulmonary hypertension. J Cardiovasc Pharmacol 41 (2003) 293-299
51. Simonneau G., Barst R.J., Galie N., et al. Treprostinil Study Group. Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med 165 6 (2002) 800-804
52. Hoeper M.M., Schwarze M., Ehlerding S., et al. Long-term treatment of primary pulmonary hypertension with aerolozed iloprost, a prostacyclin analogue. N Engl J Med 342 (2000) 1866-1870
53. Pielsticker E., Martinez F., and Rubenfire M. Lung and heart-lung transplant practice patterns in pulmonary hypertension centers. J Heart Lung Transplant 20 (2001) 1297-1304